Total Payments
$4,757
2023 Payments
$1,122
Companies
39
Transactions
324
Medicare Patients
7,103
Medicare Billing
$507,139
Payment Breakdown by Category
Food & Beverage$4,757 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,757 | 324 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $725.02 | 46 | $0 (2023) |
| Novo Nordisk Inc | $626.41 | 45 | $0 (2023) |
| ABBVIE INC. | $489.25 | 51 | $0 (2023) |
| Amgen Inc. | $295.54 | 20 | $0 (2023) |
| Amarin Pharma Inc. | $252.69 | 16 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $234.42 | 14 | $0 (2023) |
| Lilly USA, LLC | $201.99 | 18 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $180.94 | 12 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $180.00 | 13 | $0 (2022) |
| Merck Sharp & Dohme LLC | $176.93 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,122 | 76 | GlaxoSmithKline, LLC. ($217.22) |
| 2022 | $2,193 | 148 | Novo Nordisk Inc ($313.48) |
| 2021 | $1,442 | 100 | GlaxoSmithKline, LLC. ($248.67) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: RESPIRATORY | ||||||
| 09/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.14 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Diabetes | ||||||
| 08/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: PSYCHIATRY | ||||||
| 08/18/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 08/18/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Diabetes | ||||||
| 08/10/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 08/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX, AREXVY | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: PSYCHIATRY | ||||||
| 08/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/03/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Obesity | ||||||
| 07/30/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 07/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.03 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 07/24/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.02 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,100 | 3,338 | $358,490 | $171,898 |
| 2022 | 24 | 1,899 | 3,153 | $308,943 | $155,431 |
| 2021 | 22 | 1,610 | 2,246 | $197,333 | $100,762 |
| 2020 | 23 | 1,494 | 1,894 | $144,004 | $79,048 |
Total Patients
7,103
Total Services
10,631
Medicare Billing
$507,139
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 545 | 1,045 | $154,487 | $62,719 | 40.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 202 | 202 | $30,383 | $21,234 | 69.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 254 | 451 | $32,833 | $15,702 | 47.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 198 | 198 | $19,364 | $11,726 | 60.6% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 79 | 108 | $22,680 | $10,821 | 47.7% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 73 | 155 | $27,125 | $10,796 | 39.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $8,895 | $7,877 | 88.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 139 | 231 | $12,680 | $6,516 | 51.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 48 | 48 | $12,480 | $5,730 | 45.9% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 52 | 118 | $9,431 | $5,364 | 56.9% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 55 | 63 | $9,566 | $5,100 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 45 | $4,706 | $1,906 | 40.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 133 | 193 | $2,248 | $1,837 | 81.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 15 | 19 | $3,800 | $921.50 | 24.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 28 | 28 | $924.00 | $810.04 | 87.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 92 | $1,586 | $679.70 | 42.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 20 | 40 | $1,819 | $648.80 | 35.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 15 | 15 | $1,500 | $608.25 | 40.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 16 | 16 | $595.36 | $259.20 | 43.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 17 | 18 | $289.26 | $236.16 | 81.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 12 | 44 | $226.60 | $184.80 | 81.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 14 | $95.76 | $75.04 | 78.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 32 | 34 | $237.60 | $74.80 | 31.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 13 | $339.82 | $44.40 | 13.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 18 | $38.88 | $17.46 | 44.9% |
About Mary Harding, APRN
Mary Harding, APRN is a Family healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2015. The National Provider Identifier (NPI) number assigned to this provider is 1639557531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Harding, APRN has received a total of $4,757 in payments from pharmaceutical and medical device companies, with $1,122 received in 2023. These payments were reported across 324 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($4,757).
As a Medicare-enrolled provider, Harding has provided services to 7,103 Medicare beneficiaries, totaling 10,631 services with total Medicare billing of $507,139. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Family
- Location Little River, SC
- Active Since 05/12/2015
- Last Updated 11/02/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1639557531
Products in Payments
- TRELEGY ELLIPTA (Drug) $725.02
- VRAYLAR (Drug) $290.97
- Ozempic (Drug) $286.05
- Rybelsus (Drug) $261.32
- Vascepa (Drug) $252.69
- GEMTESA (Drug) $211.61
- XARELTO (Drug) $180.94
- FARXIGA (Drug) $180.00
- TRADJENTA (Drug) $172.45
- Otezla (Drug) $149.98
- BELSOMRA (Drug) $143.14
- ENTRESTO (Drug) $124.15
- INJECTAFER (Drug) $107.07
- Adlarity (Drug) $101.40
- EVENITY (Biological) $90.03
- JARDIANCE (Drug) $78.77
- MYRBETRIQ (Drug) $78.69
- QULIPTA (Drug) $78.54
- REXULTI (Drug) $77.98
- Yupelri (Drug) $71.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Little River
Sara Lara, Np-C, NP-C
Family — Payments: $7,666
Family $7,666
Mrs. Shannon Hussey, Fnp, FNP
Family — Payments: $5,065
Family $5,065
Jamie Stevens, Fnp-C, FNP-C
Family — Payments: $2,827
Family $2,827
Ashleigh Hotaling
Family — Payments: $2,322
Family $2,322
Lyn-Marie Kuball, Fnp, FNP
Family — Payments: $1,823
Family $1,823
Amanda Calhoun, Np-C, NP-C
Family — Payments: $1,795
Family $1,795